Cancer News and Research

Latest Cancer News and Research

QIAGEN launches careHPV Test in India for prevention of cervical cancer among women

QIAGEN N.V. today announced the commercial launch in India of its careHPV™ Test, the only molecular diagnostic for high-risk human papillomavirus (HPV) designed to screen women in settings with limited healthcare infrastructure, such as areas lacking electricity, water or laboratories.

From QIAGEN Manchester Limited 26 Feb 2014

Study shows promising results for new treatment approach in follicular lymphoma

A study led by Manchester scientists has shown promising results for a new treatment approach in follicular lymphoma.

From The University of Manchester 26 Feb 2014

Biothera’s Phase 2b clinical trial in NSCLC presented at International Association for the Study of Lung Cancer

Biothera presented results of its Phase 2b clinical trial in non-small cell lung cancer (NSCLC) this past weekend to top clinicians and scientists at the invitation-only International Association for the Study of Lung Cancer meeting on targeted therapies in Santa Monica, CA.

26 Feb 2014

Researchers discover how byproducts from bacteria prevalent in gum disease incite growth of deadly tumors

Researchers from Case Western Reserve University have discovered how byproducts in the form of small fatty acids from two bacteria prevalent in gum disease incite the growth of deadly Kaposi's sarcoma-related (KS) lesions and tumors in the mouth.

26 Feb 2014

Engineers develop paper test that could improve diagnosis rates for cancer

Cancer rates in developing nations have climbed sharply in recent years, and now account for 70 percent of cancer mortality worldwide. Early detection has been proven to improve outcomes, but screening approaches such as mammograms and colonoscopy, used in the developed world, are too costly to be implemented in settings with little medical infrastructure.

26 Feb 2014

Study identifies enzyme with key role in precancerous lesions

Cancer of the pancreas is usually not detected until it's too late to cure. But precursor lesions that form in the pancreas and its ducts can signal the disease before it strikes, and when caught early enough, they can be prevented from progressing to become cancer.

26 Feb 2014

Preventive oophorectomy reduces risks of ovarian, breast cancers in women with BRCA mutation

Women who carry a BRCA gene mutation and opt for a preventive oophorectomy, or ovary removal surgery, have a 77 per cent lower risk of death than those who do not, according to a new study led by Women's College Hospital's Amy Finch and Dr. Steven Narod.

26 Feb 2014

Johns Hopkins researchers use tiny particles to train immune systems of mice to fight melanoma

Using tiny particles designed to target cancer-fighting immune cells, Johns Hopkins researchers have trained the immune systems of mice to fight melanoma, a deadly skin cancer. The experiments, described tk on the website of ACS Nano, represent a significant step toward using nanoparticles and magnetism to treat a variety of conditions, the researchers say.

26 Feb 2014

Health law attack ads under the microscope

As congressional races heat up, political ads related to the health law move into the realm of fact-checking and demands for proof.

26 Feb 2014

Researcher identifies ''conductor'' in development of muscle tissue

A team led by Jean-Fran-ois C-t-, researcher at the IRCM, identified a ''conductor'' in the development of muscle tissue. The discovery, published online yesterday by the scientific journal Proceedings of the National Academy of Sciences (PNAS), could have an important impact on the treatment of muscular diseases such as myopathies and muscular dystrophies.

26 Feb 2014

Unusual EGFR mutation should influence advanced NSCLC treatment choice

Non-small-cell lung cancer patients with very unusual epidermal growth factor receptor mutations may be more likely to be benefit from first-line chemotherapy than a tyrosine kinase inhibitor, research suggests.

25 Feb 2014

Sedentary behaviour has unclear link with prostate cancer risk

Sedentary behaviour is not a clearcut risk factor for prostate cancer, analysis of a large population-based cohort indicates.

25 Feb 2014

Partial nephrectomy may offer younger renal cancer patients survival advantage

Partial nephrectomy may offer younger patients with localized renal cancer a distinct survival advantage compared with the complete removal of the kidney, US research suggests.

25 Feb 2014

Perioperative blood transfusion worsens kidney cancer patients’ survival

Patients who receive blood transfusions around the time of their surgery for nonmetastatic renal cell carcinoma have a worse chance of survival than those who do not, results of a large US study suggest.

25 Feb 2014

DiFusion gets CE Mark, European clearance to market CleanFuze antimicrobial orthobiologic polymer

DiFusion Incorporated announced today that the company has received a CE Mark and European clearance to market and implant its new CleanFuze antimicrobial orthobiologic polymer. "We are extremely gratified to announce European clearance of our CleanFuze line of antimicrobial spinal implants. This material has been in development for over five years and attaining this milestone represents significant value for our shareholders," commented DiFusion Cofounder and CEO Derrick Johns.

25 Feb 2014

Seno Medical Instruments sells $34.6 million of $39 million Series C equity funding round

Seno Medical Instruments, Inc., the company pioneering opto-acoustic imaging as a tool to improve the process of diagnosing breast cancer, today announced that it has sold $34.6 million of a $39 million Series C equity funding round from existing investors with the lead investment from MedCare Investment Funds.

25 Feb 2014

Researchers produce extremely accurate and detailed images of "toxic injections"

Bacteria have developed many different ways of smuggling their toxic cargo into cells. Tripartite Tc toxin complexes, which are used by bacteria like the plague pathogen Yersinia pestis and the insect pathogen Photorhabdus luminescens, are particularly unusual.

25 Feb 2014

AMIC provides report on FDA pre-market notification related to brachytherapy cancer product

Advanced Medical Isotope Corporation ("AMIC"), a company engaged in the development, production and distribution of medical isotopes focused on yttrium-90 brachytherapy devices, today announced that it has received a response from the FDA to its pre-market notification to the FDA pursuant to Section 510(k) of the U.S. Food, Drug and Cosmetic Act for its Yttrium-90 (Y-90) RadioGel(tm) patented brachytherapy cancer product.

25 Feb 2014

Experts offer eight ways to help prevent colorectal cancer

Colorectal cancer does not always manifest in symptoms, which may include blood in or on the stool, constant stomach pains, and unexplainable weight loss. "Colon cancer is common in both men and women.

25 Feb 2014

Isis Pharmaceuticals provides update on ISIS-SMNRx Phase 2 study in infants with SMA

Isis Pharmaceuticals, Inc. today provided an update on its ongoing open label, multiple dose Phase 2 study of ISIS-SMNRx in infants with spinal muscular atrophy (SMA).

25 Feb 2014

Cancer News and Research

Latest Cancer News and Research

QIAGEN launches careHPV Test in India for prevention of cervical cancer among women

Study shows promising results for new treatment approach in follicular lymphoma

Biothera’s Phase 2b clinical trial in NSCLC presented at International Association for the Study of Lung Cancer

Researchers discover how byproducts from bacteria prevalent in gum disease incite growth of deadly tumors

Engineers develop paper test that could improve diagnosis rates for cancer

Study identifies enzyme with key role in precancerous lesions

Preventive oophorectomy reduces risks of ovarian, breast cancers in women with BRCA mutation

Johns Hopkins researchers use tiny particles to train immune systems of mice to fight melanoma

Health law attack ads under the microscope

Researcher identifies ''conductor'' in development of muscle tissue

Unusual EGFR mutation should influence advanced NSCLC treatment choice

Sedentary behaviour has unclear link with prostate cancer risk

Partial nephrectomy may offer younger renal cancer patients survival advantage

Perioperative blood transfusion worsens kidney cancer patients’ survival

DiFusion gets CE Mark, European clearance to market CleanFuze antimicrobial orthobiologic polymer

Seno Medical Instruments sells $34.6 million of $39 million Series C equity funding round

Researchers produce extremely accurate and detailed images of "toxic injections"

AMIC provides report on FDA pre-market notification related to brachytherapy cancer product

Experts offer eight ways to help prevent colorectal cancer

Isis Pharmaceuticals provides update on ISIS-SMNRx Phase 2 study in infants with SMA

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Newsletters you may be interested in